Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-09

Clinical Trial Update: Effects of Saccharomyces Boulardii CNCM I-745 on Antibiotic-Associated Perturbation in Children Treated for Acute Respiratory Infections (RESTORE Study) [Phase 4]

View source ↗

Summary

Clinical trial update indicates the Phase 4 RESTORE study evaluating Saccharomyces boulardii CNCM I-745 for antibiotic-associated perturbation in children treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saccharomyces boulardii CNCM I-745 (Saccharomyces boulardii)

Snippet

Sponsor: Eskisehir Osmangazi University | Conditions: Antibiotic Associated Diarrhea, Acute Otitis Media | Phase 4 | Status: ACTIVE_NOT_RECRUITING